ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,397,755 | -23.5% | 439,955 | -5.8% | 0.07% | -15.3% |
| Q2 2023 | $3,135,489 | -24.0% | 467,286 | -0.0% | 0.08% | -28.6% |
| Q1 2023 | $4,127,098 | +201714.1% | 467,395 | +74.6% | 0.12% | +85.9% |
| Q4 2022 | $2,045 | -99.9% | 267,631 | -4.0% | 0.06% | 0.0% |
| Q3 2022 | $1,985,000 | -16.5% | 278,731 | -5.2% | 0.06% | -11.1% |
| Q2 2022 | $2,378,000 | -46.2% | 293,953 | -7.6% | 0.07% | -31.4% |
| Q1 2022 | $4,416,000 | -53.6% | 318,145 | -6.3% | 0.10% | -45.0% |
| Q4 2021 | $9,525,000 | +1.0% | 339,461 | +22.4% | 0.19% | -2.1% |
| Q3 2021 | $9,427,000 | -28.3% | 277,343 | -13.8% | 0.20% | -17.4% |
| Q2 2021 | $13,154,000 | +14.9% | 321,921 | +13.2% | 0.24% | +11.3% |
| Q1 2021 | $11,446,000 | -34.8% | 284,293 | -4.2% | 0.21% | -36.5% |
| Q4 2020 | $17,550,000 | +10.3% | 296,806 | -9.3% | 0.33% | -20.9% |
| Q3 2020 | $15,913,000 | -11.8% | 327,230 | -12.3% | 0.42% | -17.7% |
| Q2 2020 | $18,048,000 | +68.5% | 373,047 | -3.3% | 0.51% | +33.6% |
| Q1 2020 | $10,712,000 | +21.1% | 385,590 | +30.5% | 0.38% | +70.7% |
| Q4 2019 | $8,843,000 | – | 295,549 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |